Skip to main content
Erschienen in: European Radiology 7/2018

05.02.2018 | Hepatobiliary-Pancreas

Imaging prediction of nonalcoholic steatohepatitis using computed tomography texture analysis

verfasst von: Shotaro Naganawa, Kenichiro Enooku, Ryosuke Tateishi, Hiroyuki Akai, Koichiro Yasaka, Junji Shibahara, Tetsuo Ushiku, Osamu Abe, Kuni Ohtomo, Shigeru Kiryu

Erschienen in: European Radiology | Ausgabe 7/2018

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To determine if texture analysis of non-contrast-enhanced CT (NECT) images is able to predict nonalcoholic steatohepatitis (NASH).

Methods

NECT images from 88 patients who underwent a liver biopsy for the diagnosis of suspected NASH were assessed and texture feature parameters were obtained without and with filtration. The patient population was divided into a predictive learning dataset and a validation dataset, and further divided into groups according to the prediction of liver fibrosis as assessed by hyaluronic acid levels. The reference standard was the histological result of a liver biopsy. A predictive model for NASH was developed using parameters derived from the learning dataset that demonstrated areas under the receiver operating characteristic curve (AUC) of >0.65. The resulting model was then applied to the validation dataset.

Results

In patients without suspected fibrosis, the texture parameter mean without filter and skewness with a 2-mm filter were selected for the NASH prediction model. The AUC of the predictive model for the validation dataset was 0.94 and the accuracy was 94%. In patients with suspicion of fibrosis, the mean without filtration and kurtosis with a 4-mm filter were selected for the NASH prediction model. The AUC for the validation dataset was 0.60 and the accuracy was 42%.

Conclusions

In patients without suspicion of fibrosis, NECT texture analysis effectively predicted NASH.

Key Points

• In patients without suspicion of fibrosis, NECT texture analysis effectively predicted NASH.
• The mean without filtration and skewness with a 2-mm filter were modest predictors of NASH in patients without suspicion of liver fibrosis.
• Hepatic fibrosis masks the characteristic texture features of NASH.
Literatur
1.
Zurück zum Zitat Lazo M, Hernaez R, Eberhardt MS et al (2013) Prevalence of nonalcoholic fatty liver disease in the United States: The Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol 178:38–45CrossRefPubMedPubMedCentral Lazo M, Hernaez R, Eberhardt MS et al (2013) Prevalence of nonalcoholic fatty liver disease in the United States: The Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol 178:38–45CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Goh GB-B, McCullough AJ (2016) Natural history of nonalcoholic fatty liver disease. Dig Dis Sci 61:1226–1233CrossRefPubMed Goh GB-B, McCullough AJ (2016) Natural history of nonalcoholic fatty liver disease. Dig Dis Sci 61:1226–1233CrossRefPubMed
3.
Zurück zum Zitat Chalasani N, Younossi Z, Lavine JE et al (2012) The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55:2005–2023CrossRefPubMed Chalasani N, Younossi Z, Lavine JE et al (2012) The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55:2005–2023CrossRefPubMed
4.
Zurück zum Zitat Salman AAA, Aboelfadl SAE, Heagzy MAE (2016) New era for usage of serum liver enzymes as a promising horizon for the prediction of non-alcoholic fatty liver disease. Open Access Maced J Med Sci 4:348–352CrossRefPubMedPubMedCentral Salman AAA, Aboelfadl SAE, Heagzy MAE (2016) New era for usage of serum liver enzymes as a promising horizon for the prediction of non-alcoholic fatty liver disease. Open Access Maced J Med Sci 4:348–352CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Pulzi FB, Cisternas R, Melo MR et al (2011) New clinical score to diagnose nonalcoholic steatohepatitis in obese patients. Diabetol Metab Syndr 3:3CrossRefPubMedPubMedCentral Pulzi FB, Cisternas R, Melo MR et al (2011) New clinical score to diagnose nonalcoholic steatohepatitis in obese patients. Diabetol Metab Syndr 3:3CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Kwok R, Tse Y-K, Wong GL-H et al (2014) Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease – the role of transient elastography and plasma cytokeratin-18 fragments. Aliment Pharmacol Ther 39:254–269CrossRefPubMed Kwok R, Tse Y-K, Wong GL-H et al (2014) Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease – the role of transient elastography and plasma cytokeratin-18 fragments. Aliment Pharmacol Ther 39:254–269CrossRefPubMed
7.
Zurück zum Zitat Verma S, Jensen D, Hart J, Mohanty SR (2013) Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD). Liver Int 33:1398–1405CrossRefPubMed Verma S, Jensen D, Hart J, Mohanty SR (2013) Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD). Liver Int 33:1398–1405CrossRefPubMed
8.
Zurück zum Zitat Cusi K, Chang Z, Harrison S et al (2014) Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease. J Hepatol 60:167–174CrossRefPubMed Cusi K, Chang Z, Harrison S et al (2014) Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease. J Hepatol 60:167–174CrossRefPubMed
9.
Zurück zum Zitat Daginawala N, Li B, Buch K et al (2016) Using texture analyses of contrast enhanced CT to assess hepatic fibrosis. Eur J Radiol 85:511–517CrossRefPubMed Daginawala N, Li B, Buch K et al (2016) Using texture analyses of contrast enhanced CT to assess hepatic fibrosis. Eur J Radiol 85:511–517CrossRefPubMed
10.
Zurück zum Zitat Zhang X, Gao X, Liu BJ et al (2015) Effective staging of fibrosis by the selected texture features of liver: Which one is better, CT or MR imaging? Comput Med Imaging Graph 46:227–236CrossRefPubMed Zhang X, Gao X, Liu BJ et al (2015) Effective staging of fibrosis by the selected texture features of liver: Which one is better, CT or MR imaging? Comput Med Imaging Graph 46:227–236CrossRefPubMed
11.
Zurück zum Zitat Kayaaltı Ö, Aksebzeci BH, Karahan İÖ et al (2014) Liver fibrosis staging using CT image texture analysis and soft computing. Appl Soft Comput 25:399–413CrossRef Kayaaltı Ö, Aksebzeci BH, Karahan İÖ et al (2014) Liver fibrosis staging using CT image texture analysis and soft computing. Appl Soft Comput 25:399–413CrossRef
12.
Zurück zum Zitat Davnall F, Yip CSP, Ljungqvist G et al (2012) Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? Insights Imaging 3:573–589CrossRefPubMedPubMedCentral Davnall F, Yip CSP, Ljungqvist G et al (2012) Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? Insights Imaging 3:573–589CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Raman SP, Schroeder JL, Huang P et al (2015) Preliminary data using computed tomography texture analysis for the classification of hypervascular liver lesions. J Comput Assist Tomogr 39:383–395PubMed Raman SP, Schroeder JL, Huang P et al (2015) Preliminary data using computed tomography texture analysis for the classification of hypervascular liver lesions. J Comput Assist Tomogr 39:383–395PubMed
15.
Zurück zum Zitat Kassner A, Thornhill RE (2010) Texture analysis: a review of neurologic MR imaging applications. AJNR Am J Neuroradiol 31:809–816CrossRefPubMed Kassner A, Thornhill RE (2010) Texture analysis: a review of neurologic MR imaging applications. AJNR Am J Neuroradiol 31:809–816CrossRefPubMed
16.
Zurück zum Zitat Kiryu S, Akai H, Nojima M et al (2017) Impact of hepatocellular carcinoma heterogeneity on computed tomography as a prognostic indicator. Sci Rep 7:12689 Kiryu S, Akai H, Nojima M et al (2017) Impact of hepatocellular carcinoma heterogeneity on computed tomography as a prognostic indicator. Sci Rep 7:12689
17.
Zurück zum Zitat Yasaka K, Akai H, Nojima M et al (2017) Quantitative computed tomography texture analysis for estimating histological subtypes of thymic epithelial tumors. Eur J Radiol 92:84–92CrossRefPubMed Yasaka K, Akai H, Nojima M et al (2017) Quantitative computed tomography texture analysis for estimating histological subtypes of thymic epithelial tumors. Eur J Radiol 92:84–92CrossRefPubMed
18.
Zurück zum Zitat Ganeshan B, Abaleke S, Young RCD et al (2010) Texture analysis of non-small cell lung cancer on unenhanced computed tomography: initial evidence for a relationship with tumour glucose metabolism and stage. Cancer Imaging 10:137–143CrossRefPubMedPubMedCentral Ganeshan B, Abaleke S, Young RCD et al (2010) Texture analysis of non-small cell lung cancer on unenhanced computed tomography: initial evidence for a relationship with tumour glucose metabolism and stage. Cancer Imaging 10:137–143CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Wu Z, Matsui O, Kitao A et al (2015) Hepatitis C related chronic liver cirrhosis: feasibility of texture analysis of MR images for classification of fibrosis stage and necroinflammatory activity grade. PLoS One 10:e0118297CrossRefPubMedPubMedCentral Wu Z, Matsui O, Kitao A et al (2015) Hepatitis C related chronic liver cirrhosis: feasibility of texture analysis of MR images for classification of fibrosis stage and necroinflammatory activity grade. PLoS One 10:e0118297CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Kleiner DE, Brunt EM, Van Natta M et al (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313–1321CrossRefPubMed Kleiner DE, Brunt EM, Van Natta M et al (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313–1321CrossRefPubMed
21.
Zurück zum Zitat Suzuki A, Angulo P, Lymp J et al (2005) Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease. Liver Int 25:779–786CrossRefPubMed Suzuki A, Angulo P, Lymp J et al (2005) Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease. Liver Int 25:779–786CrossRefPubMed
22.
Zurück zum Zitat Pavlides M, Banerjee R, Tunnicliffe EM et al (2017) Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity. Liver Int 37:1065–1073CrossRefPubMedPubMedCentral Pavlides M, Banerjee R, Tunnicliffe EM et al (2017) Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity. Liver Int 37:1065–1073CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Valls C, Iannacconne R, Alba E et al (2006) Fat in the liver: diagnosis and characterization. Eur Radiol 16:2292–2308CrossRefPubMed Valls C, Iannacconne R, Alba E et al (2006) Fat in the liver: diagnosis and characterization. Eur Radiol 16:2292–2308CrossRefPubMed
24.
Zurück zum Zitat Ahn SJ, Kim JH, Park SJ, Han JK (2016) Prediction of the therapeutic response after FOLFOX and FOLFIRI treatment for patients with liver metastasis from colorectal cancer using computerized CT texture analysis. Eur J Radiol 85:1867–1874CrossRefPubMed Ahn SJ, Kim JH, Park SJ, Han JK (2016) Prediction of the therapeutic response after FOLFOX and FOLFIRI treatment for patients with liver metastasis from colorectal cancer using computerized CT texture analysis. Eur J Radiol 85:1867–1874CrossRefPubMed
25.
Zurück zum Zitat Nketiah G, Elschot M, Kim E et al (2017) T2-weighted MRI-derived textural features reflect prostate cancer aggressiveness: preliminary results. Eur Radiol 27:3050–3059CrossRefPubMed Nketiah G, Elschot M, Kim E et al (2017) T2-weighted MRI-derived textural features reflect prostate cancer aggressiveness: preliminary results. Eur Radiol 27:3050–3059CrossRefPubMed
26.
Zurück zum Zitat Molina D, Pérez-Beteta J, Luque B et al (2016) Tumour heterogeneity in glioblastoma assessed by MRI texture analysis: a potential marker of survival. Br J Radiol 89:20160242CrossRefPubMedCentral Molina D, Pérez-Beteta J, Luque B et al (2016) Tumour heterogeneity in glioblastoma assessed by MRI texture analysis: a potential marker of survival. Br J Radiol 89:20160242CrossRefPubMedCentral
27.
Zurück zum Zitat Kaneda H, Hashimoto E, Yatsuji S et al (2006) Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease. J Gastroenterol Hepatol 21:1459–1465PubMed Kaneda H, Hashimoto E, Yatsuji S et al (2006) Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease. J Gastroenterol Hepatol 21:1459–1465PubMed
28.
Zurück zum Zitat Mackin D, Fave X, Zhang L et al (2015) Measuring computed tomography scanner variability of radiomics features. Investig Radiol 50:757–765CrossRef Mackin D, Fave X, Zhang L et al (2015) Measuring computed tomography scanner variability of radiomics features. Investig Radiol 50:757–765CrossRef
29.
Zurück zum Zitat Mahmoud-Ghoneim D, Toussaint G, Constans JM, De Certaines JD (2003) Three dimensional texture analysis in MRI: a preliminary evaluation in gliomas. Magn Reson Imaging 21:983–987CrossRefPubMed Mahmoud-Ghoneim D, Toussaint G, Constans JM, De Certaines JD (2003) Three dimensional texture analysis in MRI: a preliminary evaluation in gliomas. Magn Reson Imaging 21:983–987CrossRefPubMed
30.
Zurück zum Zitat Park HJ, Kim JH, Choi SY et al (2017) Prediction of therapeutic response of hepatocellular carcinoma to transcatheter arterial chemoembolization based on pretherapeutic dynamic CT and textural findings. AJR Am J Roentgenol 209:W211–W220CrossRefPubMed Park HJ, Kim JH, Choi SY et al (2017) Prediction of therapeutic response of hepatocellular carcinoma to transcatheter arterial chemoembolization based on pretherapeutic dynamic CT and textural findings. AJR Am J Roentgenol 209:W211–W220CrossRefPubMed
31.
Zurück zum Zitat Chen W, Giger ML, Li H et al (2007) Volumetric texture analysis of breast lesions on contrast-enhanced magnetic resonance images. Magn Reson Med 58:562–571CrossRefPubMed Chen W, Giger ML, Li H et al (2007) Volumetric texture analysis of breast lesions on contrast-enhanced magnetic resonance images. Magn Reson Med 58:562–571CrossRefPubMed
32.
Metadaten
Titel
Imaging prediction of nonalcoholic steatohepatitis using computed tomography texture analysis
verfasst von
Shotaro Naganawa
Kenichiro Enooku
Ryosuke Tateishi
Hiroyuki Akai
Koichiro Yasaka
Junji Shibahara
Tetsuo Ushiku
Osamu Abe
Kuni Ohtomo
Shigeru Kiryu
Publikationsdatum
05.02.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 7/2018
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-017-5270-5

Weitere Artikel der Ausgabe 7/2018

European Radiology 7/2018 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.